ESCAPE10: Epidemiology, Risk Factors, and Outcomes of Severe Community-acquired Pneumonia in Elderly Patients Acquired Pneumonia in Elderly Patients
Key facts
- Who runs it
- Joan Sabater-Riera
- Where
- Croatia, France, Greece, Italy, Portugal, and Spain18 sites in 6 countriesChoose a country to see its sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 500 people, planned
- Started
- 1 May 2025
- Expected to end
- 30 Nov 2026
- Type of study
- Observational
- Record updated
- 15 May 2026
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patients aged 65 years-old or older
- Patients with clinically and radiologically (Chest X-Ray (CXR), Computerized Tomography (CT) or lung ultrasound (LUS) confirmed pneumonia
- Patients fulfilling the protocol definition of sCAP
Who cannot take part
- Patients receiving comfort care only or with documented decisions to forgo intensive medical interventions
- Age < 65 years
- Recent hospitalization (above 48 h within the past 10 days) in acute healthcare settings
- Terminal events or imminent death
Where is this trial?
It has sites in 6 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
The ESCAPE 10 study is a multinational, retrospective, observational cohort study that aims to investigate the epidemiology and outcome determinants of severe community-acquired pneumonia (sCAP) in elderly patients (≥65 years). Conducted across multiple European countries, the study will include at least 500 patients admitted to acute care hospitals with radiologically confirmed sCAP, with enrollment distributed evenly between epidemic (winter) and non-epidemic (summer) seasons.
Read full original descriptionShow less
The primary objective is to assess 28-day mortality. Secondary objectives include evaluating in-hospital mortality, pneumonia-related complications, Intensive Care Unit (ICU) stay, ventilation needs, and identifying clinical risk factors associated with poor outcomes. Additionally, the study aims to propose a set of quality indicators for sCAP management and assess gender-related differences and clinical subphenotypes in the post-COVID-19 era.
Data will be retrospectively collected from medical records, with no interventions applied. Findings from this study are expected to guide improvements in clinical care, patient safety, and outcome prediction models in elderly populations with sCAP.
The group in the trial
- Severe Community-Acquired Pneumonia in the Elderly
Participants aged 65 years or older who were hospitalized with radiologically confirmed severe community-acquired pneumonia (sCAP), as defined by protocol criteria. All patients included met clinical and radiological criteria for sCAP and were admitted to an acute care hospital during the defined inclusion period.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Escape 10 Study: Epidemiology and Determinants of Outcomes of Severe Community-acquired Pneumonia in the Elderly
- Record updated
- 15 May 2026